StockWatch
·
Pharmaceuticals
Business Update26 Mar 2026, 03:10 pm

Welcure Drugs & Pharmaceuticals Ltd Closes Trading Window for 4th Quarter and Annual Year Ended 31 March, 2026

AI Summary

Welcure Drugs & Pharmaceuticals Ltd has announced the closure of the trading window for all Designated Persons, Designated Employees, Specified Persons and their immediate relatives. The closure is in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company's Internal Code of Conduct. The trading window will remain closed from April 01, 2026 till the expiry of 48 hours after the Declaration of Audited Standalone Financial Results of 4th Quarter and Annual Year Ended March 31, 2026 become generally available information.

Key Highlights

  • Welcure Drugs & Pharmaceuticals Ltd closes trading window for 4th quarter and annual year ended 31 March, 2026
  • Closure in accordance with Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company's Internal Code of Conduct
  • Trading window to remain closed from April 01, 2026 till the expiry of 48 hours after the Declaration of Audited Standalone Financial Results become generally available information
  • Applies to all Designated Persons, Designated Employees, Specified Persons and their immediate relatives